34 related articles for article (PubMed ID: 17089047)
1. Distribution of Tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage.
Gelmini S; Poggesi M; Pinzani P; Mannurita SC; Cianchi F; Valanzano R; Orlando C
Oncol Rep; 2006 Dec; 16(6):1261-6. PubMed ID: 17089047
[TBL] [Abstract][Full Text] [Related]
2. Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients.
Shebzukhov YV; Lavrik IN; Karbach J; Khlgatian SV; Koroleva EP; Belousov PV; Kashkin KN; Knuth A; Jager E; Chi NW; Kuprash DV; Nedospasov SA
Cancer Immunol Immunother; 2008 Jun; 57(6):871-81. PubMed ID: 18026951
[TBL] [Abstract][Full Text] [Related]
3. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
4. Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression.
Antony F; Kang X; Pundkar C; Wang C; Mishra A; Chen P; Babu RJ; Suryawanshi A
Int J Pharm; 2023 Jun; 640():123043. PubMed ID: 37172631
[TBL] [Abstract][Full Text] [Related]
5. Unravelling the Mechanistic Role of Quinazolinone Pharmacophore in the Inhibitory Activity of Bis-quinazolinone Derivative on Tankyrase-1 in the Treatment of Colorectal Cancer (CRC) and Non-small Cell Lung Cancer (NSCLC): A Computational Approach.
Okunlola FO; Akawa OB; Subair TI; Omolabi KF; Soliman MES
Cell Biochem Biophys; 2022 Mar; 80(1):1-10. PubMed ID: 34453681
[TBL] [Abstract][Full Text] [Related]
6. Tankyrases/β-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines.
Huang J; Qu Q; Guo Y; Xiang Y; Feng D
J Cancer; 2020; 11(2):432-440. PubMed ID: 31897238
[No Abstract] [Full Text] [Related]
7. Biological Functions of TNKS1 and Its Relationship with Wnt/β-Catenin Pathway in Astrocytoma.
Chen M; Tang B; Xie S; Yan J; Yang L; Zhou X; Zeng E
Onco Targets Ther; 2019; 12():10841-10850. PubMed ID: 31849489
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity.
Eisemann T; Pascal JM
Cell Mol Life Sci; 2020 Jan; 77(1):19-33. PubMed ID: 31754726
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of XAV939 on the proliferation of small-cell lung cancer H446 cells and Wnt/β-catenin signaling pathway
Pan F; Shen F; Yang L; Zhang L; Guo W; Tian J
Oncol Lett; 2018 Aug; 16(2):1953-1958. PubMed ID: 30008888
[TBL] [Abstract][Full Text] [Related]
10. Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis.
Guo W; Shen F; Xiao W; Chen J; Pan F
Oncol Lett; 2017 Dec; 14(6):6585-6591. PubMed ID: 29344117
[TBL] [Abstract][Full Text] [Related]
11. The tankyrase inhibitor G007-LK inhibits small intestine LGR5
Norum JH; Skarpen E; Brech A; Kuiper R; Waaler J; Krauss S; Sørlie T
Biol Res; 2018 Jan; 51(1):3. PubMed ID: 29316982
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
Mariotti L; Pollock K; Guettler S
Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
[TBL] [Abstract][Full Text] [Related]
13. Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling.
Mariotti L; Templeton CM; Ranes M; Paracuellos P; Cronin N; Beuron F; Morris E; Guettler S
Mol Cell; 2016 Aug; 63(3):498-513. PubMed ID: 27494558
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
[TBL] [Abstract][Full Text] [Related]
15. Tankyrases: structure, function and therapeutic implications in cancer.
Haikarainen T; Krauss S; Lehtio L
Curr Pharm Des; 2014; 20(41):6472-88. PubMed ID: 24975604
[TBL] [Abstract][Full Text] [Related]
16. XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.
Tian XH; Hou WJ; Fang Y; Fan J; Tong H; Bai SL; Chen Q; Xu H; Li Y
J Exp Clin Cancer Res; 2013 Dec; 32(1):100. PubMed ID: 24308762
[TBL] [Abstract][Full Text] [Related]
17. Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.
Kato M; Nakayama M; Agata M; Yoshida K
Tumour Biol; 2013 Apr; 34(2):723-33. PubMed ID: 23247865
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in telomere maintenance genes in relation to ovarian cancer survival.
Harris HR; Vivo ID; Titus LJ; Vitonis AF; Wong JY; Cramer DW; Terry KL
Int J Mol Epidemiol Genet; 2012; 3(3):252-61. PubMed ID: 23050056
[TBL] [Abstract][Full Text] [Related]
19. Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.
Bottone MG; Santin G; Soldani C; Veneroni P; Scovassi AI; Alpini C
Eur J Histochem; 2012 Jan; 56(1):e4. PubMed ID: 22472892
[TBL] [Abstract][Full Text] [Related]
20. Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity.
Gao J; Zhang J; Long Y; Tian Y; Lu X
Pathol Oncol Res; 2011 Sep; 17(3):685-90. PubMed ID: 21455637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
